Holgersson, Georg <br/><br/>
The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  06 2017 
 - 1555-1560 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.22034/APJCP.2017.18.6.1555  doi